Comparative effectiveness of oral pharmacologic interventions for knee osteoarthritis: A network meta-analysis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, Sun-Young | - |
dc.contributor.author | Jang, Eun Jin | - |
dc.contributor.author | Nam, Seong Wan | - |
dc.contributor.author | Kwon, Hyuk Hee | - |
dc.contributor.author | Im, Seul Gi | - |
dc.contributor.author | Kim, Dam | - |
dc.contributor.author | Cho, Soo-Kyung | - |
dc.contributor.author | Kim, Dalho | - |
dc.contributor.author | Sung, Yoon-Kyoung | - |
dc.date.available | 2019-03-08T06:58:14Z | - |
dc.date.issued | 2018-11-02 | - |
dc.identifier.issn | 1439-7595 | - |
dc.identifier.issn | 1439-7609 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/3440 | - |
dc.description.abstract | Objectives: To explore the relative efficacy of oral pharmacologic interventions in the treatment of knee OA. Methods: A systematic literature review was conducted using the MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials databases to identify trials conducted in patients with knee OA with a minimum 6 weeks of follow-up. The standardized mean differences of the change from baseline to week 6 in Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain between the treatment groups were estimated using Bayesian random-effects network meta-analyses. Subgroup analyses of baseline pain status (high, pain score ≥60 mm; low, pain score <60 mm) were performed. Results: Of 4067 manuscripts, 44 were included in the evidence synthesis. Etoricoxib had the highest ranking for improving WOMAC pain (probability of being top ranked, p (best) =.43) followed by naproxen (p (best) =.12), acetaminophen (AAP) (p (best) =.04), and celecoxib (p (best) =.02). The top three ranked interventions were etoricoxib, celecoxib and aceclofenac in the higher pain group, and tramadol, celecoxib, and diclofenac in the lower pain group. Conclusion: In the overall analysis, etoricoxib, celecoxib, and aceclofenac had the highest rankings for improving WOMAC pain. The ability to improve knee OA symptoms may differ depending on baseline pain and radiologic features. © 2018, © 2018 Japan College of Rheumatology. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Taylor and Francis Ltd | - |
dc.title | Comparative effectiveness of oral pharmacologic interventions for knee osteoarthritis: A network meta-analysis | - |
dc.type | Article | - |
dc.identifier.doi | 10.1080/14397595.2018.1439694 | - |
dc.identifier.bibliographicCitation | Modern Rheumatology, v.28, no.6, pp 1021 - 1028 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000453423700015 | - |
dc.identifier.scopusid | 2-s2.0-85042912642 | - |
dc.citation.endPage | 1028 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1021 | - |
dc.citation.title | Modern Rheumatology | - |
dc.citation.volume | 28 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | Osteoarthritis | - |
dc.subject.keywordAuthor | anti-inflammatory agents | - |
dc.subject.keywordAuthor | non-steroidal | - |
dc.subject.keywordAuthor | acetaminophen | - |
dc.subject.keywordAuthor | tramadol | - |
dc.subject.keywordPlus | ISPOR TASK-FORCE | - |
dc.subject.keywordPlus | CLINICAL-PRACTICE | - |
dc.subject.keywordPlus | RECOMMENDATIONS | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | SAFETY | - |
dc.subject.keywordPlus | NSAIDS | - |
dc.subject.keywordPlus | HIP | - |
dc.relation.journalResearchArea | Rheumatology | - |
dc.relation.journalWebOfScienceCategory | Rheumatology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.